Case Studies

Metadynamics-Based Free Energy Simulations of Glutathione Binding to SARS-CoV-2 3CLpro
BioIn

Metadynamics-Based Free Energy Simulations of Glutathione Binding to SARS-CoV-2 3CLpro

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has underscored the urgent need for effective antiviral therapeutics. One of the most promising drug targets is the 3C-like protease (3CLpro), also known as the main protease (Mpro), which plays a critica…

Akhilesh CS
August 26, 2025
Read more
AI-Driven Drug Discovery: Target-Specific Molecule Generation for Cancer Pathways
BioIn

AI-Driven Drug Discovery: Target-Specific Molecule Generation for Cancer Pathways

The Target Specific module within the SyMoG/AI application represents a groundbreaking approach to synthetic molecule generation tailored to specific biological targets, focusing on drug discovery for cancer-related pathways. Leveraging machine learning model…

Akhilesh C S
December 20, 2024
Read more
Metal Docking in PRinS³: Expanding Ligand Binding Studies to Metal-Dependent Systems
BioIn

Metal Docking in PRinS3: Expanding Ligand Binding Studies to Metal-Dependent Systems

Metallo-β-lactamases (MBLs) are a critical group of enzymes that enable bacteria to resist β-lactam antibiotics, including carbapenems, which are often considered the last line of defense for treating severe bacterial infections. Carbapenems, a powerful subcl…

Megha Bose
December 20, 2024
Read more
Streamlined Protein Structure Exploration: BioIn in PRinS³ Software Suite for Effortless Protein Refinement
BioIn

Streamlined Protein Structure Exploration: BioIn in PRinS3 Software Suite for Effortless Protein Refinement

Commencing on the fascinating world of in silico studies, our journey begins with the exploration and identification of protein targets. Exploiting the power of databases like RCSB Protein Data Bank and Uniprot, we dive into the domain of protein structures.

Adhithya M
January 16, 2024
Read more
Unveiling New Molecules: Boosting Disease Datasets in a scenario of limited availability of FDA-Approved Drugs using PRinS³ Platform.
ChemIn, SyMoG/AI

Unveiling New Molecules: Boosting Disease Datasets in a scenario of limited availability of FDA-Approved Drugs using PRinS3 Platform.

The epidermal growth factor receptor (EGFR) is a key member in a group of receptors responsible for growth, carrying a built-in tyrosine kinase function.

Adhithya M
January 16, 2024
Read more
Exploring Natural Products that inhibit the Target Biliverdin Reductase in Hyperbilirubinemia using PRinS³ Platform
X-ESS

Exploring Natural Products that inhibit the Target Biliverdin Reductase in Hyperbilirubinemia using PRinS3 Platform

Hyperbilirubinemia is a form of illness characterized by an increase in blood bilirubin levels as a result of a failure to efficiently metabolize or eliminate bilirubin, a byproduct of erythrocyte breakdown. It can be traced back to irregularities in normal b…

Sakshi Singh
May 22, 2023
Read more
Identifying New Chemical Entities as Potential Therapeutic Agent for NAFLD Treatment using PRinS³ Platform
BioIn

Identifying New Chemical Entities as Potential Therapeutic Agent for NAFLD Treatment using PRinS3 Platform

Non-alcoholic fatty liver disease, a chronic liver condition not caused by alcohol or other obvious liver-damaging factors, is characterized by excessive fat deposition in hepatocytes.

Megha Bose
May 16, 2023
Read more
Insilico Drug Repurposing Approach To Identify  Drugs For The Treatment  Of Neglected Diseases using PRinS³ Platform
BioIn

Insilico Drug Repurposing Approach To Identify Drugs For The Treatment Of Neglected Diseases using PRinS3 Platform

Chagas Disease can be described as a condition in which the parasite named Trypanosoma cruzi is involved and it is the main causative agent of this disease. These parasites can enter the body through the mucous membranes and also through the breaks that are p…

Medha Dwivedi
May 16, 2023
Read more

See the platform behind the research

Every case study was produced using PRinS3. Book a demo to see how it can accelerate your programme.

Quick Links
ProductsSolutionsCareersResearch and Insights
Contact
Book a DemoEnquire about R&D ServicesApply for InternshipGet Product Support
Important Links
Privacy PolicyReturn & RefundsTerms & Condition
Address

GK Co-Works (Managed Office Spaces)
72/12, Nallurahalli Main Rd, near shell petrol pump,
Whitefield, Siddapura, Brookefield, Bengaluru,
Karnataka 560066

Phone: +91 6361546737
Email: support@prescience.in
© 2026 Prescience Insilico. All rights reserved.